Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meilan K Han

Showing results (31-40 of 484) with videos related to

Pageof 49
Sort By:
The Lancet. Respiratory Medicine|May 10, 2017
Antibiotics for COPD exacerbationsWassim W Labaki, MeiLan K Han
The Medical Clinics of North America|July 17, 2012
Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypesCarlos H Martinez, MeiLan K Han
The Lancet. Respiratory Medicine|June 12, 2020
Chronic respiratory diseases: a global viewWassim W Labaki, MeiLan K Han
The European Respiratory Journal|November 2, 2013
"The ABC of GOLD A-B-C-D"Frits M E Franssen, Meilan K Han
The New England Journal of Medicine|September 9, 2016
Symptoms in Smokers with Preserved Pulmonary FunctionPrescott G Woodruff, David Couper, MeiLan K Han
Annals of the American Thoracic Society|August 29, 2015
Regional Sparing in an Oligemic Lung Segment Supports Hematogenous Spread as a Pathogenic Mechanism in LymphangioleiomyomatosisNishant Gupta, MeiLan K Han, Francis X McCormack
The Lancet. Global Health|December 17, 2021
Understanding lung health beliefs in low-resource settingsJennifer M Wang, MeiLan K Han, Wassim W Labaki
Annual Review of Medicine|January 27, 2021
Advances in Chronic Obstructive Pulmonary DiseaseMichael C Ferrera, Wassim W Labaki, MeiLan K Han
Current Opinion in Pulmonary Medicine|October 15, 2021
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?Jennifer M Wang, MeiLan K Han, Wassim W Labaki
The Lancet. Respiratory Medicine|November 29, 2016
COPD in 2016: some answers, more questionsWassim W Labaki, Carlos H Martinez, MeiLan K Han
Pageof 49

Showing results (31-40 of 484) with videos related to

Sort By:
Pageof 49
The Lancet. Respiratory Medicine|May 10, 2017
Antibiotics for COPD exacerbationsWassim W Labaki, MeiLan K Han
The Medical Clinics of North America|July 17, 2012
Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypesCarlos H Martinez, MeiLan K Han
The Lancet. Respiratory Medicine|June 12, 2020
Chronic respiratory diseases: a global viewWassim W Labaki, MeiLan K Han
The European Respiratory Journal|November 2, 2013
"The ABC of GOLD A-B-C-D"Frits M E Franssen, Meilan K Han
The New England Journal of Medicine|September 9, 2016
Symptoms in Smokers with Preserved Pulmonary FunctionPrescott G Woodruff, David Couper, MeiLan K Han
Annals of the American Thoracic Society|August 29, 2015
Regional Sparing in an Oligemic Lung Segment Supports Hematogenous Spread as a Pathogenic Mechanism in LymphangioleiomyomatosisNishant Gupta, MeiLan K Han, Francis X McCormack
The Lancet. Global Health|December 17, 2021
Understanding lung health beliefs in low-resource settingsJennifer M Wang, MeiLan K Han, Wassim W Labaki
Annual Review of Medicine|January 27, 2021
Advances in Chronic Obstructive Pulmonary DiseaseMichael C Ferrera, Wassim W Labaki, MeiLan K Han
Current Opinion in Pulmonary Medicine|October 15, 2021
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?Jennifer M Wang, MeiLan K Han, Wassim W Labaki
The Lancet. Respiratory Medicine|November 29, 2016
COPD in 2016: some answers, more questionsWassim W Labaki, Carlos H Martinez, MeiLan K Han
Pageof 49